APA (7th ed.) Citation

R, B., A, H., PJ, S., JA, S., MA, B., N, G., . . . M, N. (2024). Long-term enhancements in antidepressant efficacy and neurogenesis: Effects of intranasal co-administration of neuropeptide Y 1 receptor (NPY1R) and galanin receptor 2 (GALR2) agonists in the ventral hippocampus. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 38(7), e23595. https://doi.org/10.1096/fj.202400087R

Chicago Style (17th ed.) Citation

R, Beltran-Casanueva, Hernández-García A, Serrano-Castro PJ, Sánchez-Pérez JA, Barbancho-Fernández MA, García-Casares N, Fuxe K, Borroto-Escuela DO, and Narváez M. "Long-term Enhancements in Antidepressant Efficacy and Neurogenesis: Effects of Intranasal Co-administration of Neuropeptide Y 1 Receptor (NPY1R) and Galanin Receptor 2 (GALR2) Agonists in the Ventral Hippocampus." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 38, no. 7 (2024): e23595. https://doi.org/10.1096/fj.202400087R.

MLA (9th ed.) Citation

R, Beltran-Casanueva, et al. "Long-term Enhancements in Antidepressant Efficacy and Neurogenesis: Effects of Intranasal Co-administration of Neuropeptide Y 1 Receptor (NPY1R) and Galanin Receptor 2 (GALR2) Agonists in the Ventral Hippocampus." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 38, no. 7, 2024, p. e23595, https://doi.org/10.1096/fj.202400087R.